Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.

 

The Arthur Giggs Diabetes & Metabolism Research Institute (AR-DMRI) promotes new discoveries and innovation across pathophysiology, diabetes related complications and treatment of type 1 and 2 diabetes. The Department of Translational Research & Cellular Therapeutics (TRCT) which is under AR-DMRI, led by Fouad Kandeel, M.D., Ph.D., has translated landmark scientific discoveries into treatments that have improved the lives of diabetic patients around the world.  TRCT focuses on stem cell biology and development, translational and clinical research, islet isolation and distribution, islet isolation and quality assessment, islet imaging, islet encapsulation, and new drug discoveries.

 

The Staff Scientist series is designed for career research professionals whose primary function is to support the research infrastructure and activities of the institution. Staff Scientists will bring special skills, knowledge and experience to research programs or institutional core laboratories.  Individuals appointed as staff scientists will receive a one-year fixed-term contract.

Qualifications

Your qualifications should include:

A Ph.D with a minimum of three years of human T cells and regulatory T cells research experience.Must have the ability to design and execute laboratory experiments, critically interpret experimental results, and present data in a clear and concise manner.Ability to participate in the preparation of grant applications, scientific publications, and IND submissions.Excellent oral and written communication skills. Demonstrated publication record in peer-reviewed scientific journals.

 

Preferred qualifications:

Proficiency in immunology and diabetes research, particularly Type 1 Diabetes (T1D).Expertise in the development of Chimeric Antigen Receptor T (CAR-T) cells.Ability to effectively develop projects in a translational research environment to meet project goals.

 

City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.

 

To learn more about our Comprehensive Benefits, please CLICK HERE.